ym 09151-2 has been researched along with cysteine in 2 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
---|---|---|---|---|---|
249 | 6 | 13 | 40,132 | 418 | 11,457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Javitch, JA; Kaback, J; Karlin, A; Li, X | 1 |
Chen, J; Fu, D; Javitch, JA | 1 |
2 other study(ies) available for ym 09151-2 and cysteine
Article | Year |
---|---|
A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.
Topics: Amino Acid Sequence; Benzamides; Binding Sites; Cell Line; Cysteine; Dopamine Antagonists; Embryo, Mammalian; Humans; Kidney; Kinetics; Mutagenesis, Site-Directed; Protein Conformation; Receptors, Dopamine D2; Recombinant Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship; Sulfonic Acids; Transfection | 1994 |
Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
Topics: Benzamides; Binding Sites; Cell Line; Cysteine; Humans; Mutagenesis, Site-Directed; Receptors, Dopamine D2; Spiperone; Structure-Activity Relationship | 1996 |